Trgovina Biocept, Inc. - BIOC CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.1310 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 2.0157 |
Odpri* | 2.0547 |
Enoletna sprememba* | 53.34% |
Dnevni razpon* | 1.966 - 2.0941 |
Razpon 52 wk | 1.99-47.70 |
Povprečni obseg (10 dni) | 877.98K |
Povprečni obseg (3 meseci) | 3.03M |
Tržna kapitalizacija | 3.01M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 1.47M |
Prihodki | 6.59M |
EPS | -65.01 |
Dividenda (donosnost v %) | N/A |
Beta | 0.93 |
Datum naslednjega zaslužka | Nov 8, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 2.0645 | 0.0594 | 2.96% | 2.0051 | 2.0941 | 1.9560 |
Jun 1, 2023 | 2.0157 | -0.0189 | -0.93% | 2.0346 | 2.1038 | 2.0055 |
May 31, 2023 | 2.1039 | -0.0091 | -0.43% | 2.1130 | 2.1233 | 1.9367 |
May 30, 2023 | 2.1137 | 0.0500 | 2.42% | 2.0637 | 2.2703 | 2.0436 |
May 26, 2023 | 2.1134 | -0.0884 | -4.01% | 2.2018 | 2.3192 | 2.0051 |
May 25, 2023 | 2.2505 | -0.1175 | -4.96% | 2.3680 | 2.3877 | 2.0546 |
May 24, 2023 | 4.1582 | -0.4705 | -10.16% | 4.6287 | 6.5274 | 4.0595 |
May 23, 2023 | 4.8417 | -0.2552 | -5.01% | 5.0969 | 5.2452 | 4.0489 |
May 22, 2023 | 4.6572 | -1.2610 | -21.31% | 5.9182 | 6.6545 | 4.6085 |
May 19, 2023 | 6.5567 | 1.3230 | 25.28% | 5.2337 | 12.8870 | 5.2008 |
May 18, 2023 | 5.3230 | 0.1877 | 3.66% | 5.1353 | 5.5269 | 5.1352 |
May 17, 2023 | 5.2651 | -1.1879 | -18.41% | 6.4530 | 6.4530 | 4.9662 |
May 16, 2023 | 0.2055 | -0.0243 | -10.57% | 0.2298 | 0.2298 | 0.2055 |
May 15, 2023 | 0.2347 | -0.0016 | -0.68% | 0.2363 | 0.2422 | 0.2297 |
May 12, 2023 | 0.2455 | 0.0010 | 0.41% | 0.2445 | 0.2455 | 0.2445 |
May 11, 2023 | 0.2462 | -0.0002 | -0.08% | 0.2464 | 0.2482 | 0.2444 |
May 10, 2023 | 0.2544 | -0.0028 | -1.09% | 0.2572 | 0.2641 | 0.2420 |
May 9, 2023 | 0.2611 | 0.0166 | 6.79% | 0.2445 | 0.2627 | 0.2372 |
May 8, 2023 | 0.2494 | 0.0113 | 4.75% | 0.2381 | 0.2495 | 0.2321 |
May 5, 2023 | 0.2605 | 0.0161 | 6.59% | 0.2444 | 0.2614 | 0.2444 |
Biocept, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Friday, July 7, 2023 | ||
Čas (UTC) (UTC) 20:30 | Država US
| Dogodek Biocept Inc Annual Shareholders Meeting Biocept Inc Annual Shareholders MeetingForecast -Previous - |
Wednesday, November 8, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q2 2023 Biocept Inc Earnings Release Q2 2023 Biocept Inc Earnings ReleaseForecast -Previous - |
Monday, November 20, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q3 2023 Biocept Inc Earnings Release Q3 2023 Biocept Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 25.858 | 61.249 | 27.4614 | 5.52857 | 3.2503 |
Prihodki | 25.858 | 61.249 | 27.4614 | 5.52857 | 3.2503 |
Celotni stroški prihodkov | 28.44 | 37.764 | 21.3368 | 10.9775 | 10.0517 |
Bruto dobiček | -2.582 | 23.485 | 6.12461 | -5.44895 | -6.80144 |
Celotni odhodki iz poslovanja | 57.841 | 63.658 | 42.9296 | 28.5855 | 27.509 |
Celotna prodaja/splošni/upravni stroški Odhodki | 23.24 | 20.934 | 16.3726 | 12.911 | 12.9887 |
Raziskave in razvoj | 6.161 | 4.96 | 5.22028 | 4.69702 | 4.46857 |
Prihodki iz poslovanja | -31.983 | -2.409 | -15.4683 | -23.0569 | -24.2587 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.316 | -0.29 | -0.23654 | -0.24998 | -0.31098 |
Drugo, neto | 0.087 | 0 | -2.10211 | -1.83112 | 0 |
Čisti dobiček pred obdavčitvijo | -32.212 | -2.699 | -17.8069 | -25.138 | -24.5697 |
Čisti dobiček po davkih | -32.087 | -2.824 | -17.8069 | -25.138 | -24.5716 |
Čisti dobiček pred dodatnimi postavkami | -32.087 | -2.824 | -17.8069 | -25.138 | -24.5716 |
Čisti dobiček | -32.087 | -2.824 | -17.8069 | -25.138 | -24.5716 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -32.087 | -2.824 | -17.8097 | -25.2596 | -25.208 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -32.087 | -2.824 | -17.8097 | -25.2596 | -25.208 |
Popravljen čisti dobiček | -32.087 | -2.824 | -17.8097 | -25.2596 | -25.208 |
Popravljene ponderirane povprečne delnice | 0.56513 | 0.49253 | 0.39484 | 0.06886 | 0.00933 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -56.7784 | -5.7337 | -45.1058 | -366.811 | -2702.82 |
Popravljen normalizirani dobiček na enoto čistega dobička | -56.7784 | -5.7337 | -45.1058 | -366.811 | -2702.82 |
Skupaj izredne postavke | 0 | ||||
Dividends per Share - Common Stock Primary Issue | |||||
Total Adjustments to Net Income | 0 | -0.00277 | -0.12157 | -0.63637 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 0.673 | 25.858 | 1.007 | 10.611 | 19.945 |
Prihodki | 0.673 | 25.858 | 1.007 | 10.611 | 19.945 |
Celotni stroški prihodkov | 3.028 | 28.44 | 5.776 | 8.023 | 10.334 |
Bruto dobiček | -2.355 | -2.582 | -4.769 | 2.588 | 9.611 |
Celotni odhodki iz poslovanja | 7.771 | 57.841 | 11.164 | 15.708 | 22.094 |
Celotna prodaja/splošni/upravni stroški Odhodki | 3.703 | 23.24 | 4.022 | 5.956 | 9.914 |
Raziskave in razvoj | 1.04 | 6.161 | 1.366 | 1.729 | 1.846 |
Prihodki iz poslovanja | -7.098 | -31.983 | -10.157 | -5.097 | -2.149 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.046 | -0.316 | -0.052 | -0.155 | -0.061 |
Drugo, neto | 0.087 | 0.084 | |||
Čisti dobiček pred obdavčitvijo | -7.144 | -32.212 | -10.125 | -5.252 | -2.21 |
Čisti dobiček po davkih | -7.144 | -32.087 | -10.125 | -5.252 | -2.21 |
Čisti dobiček pred dodatnimi postavkami | -7.144 | -32.087 | -10.125 | -5.252 | -2.21 |
Čisti dobiček | -7.144 | -32.087 | -10.125 | -5.252 | -2.21 |
Total Adjustments to Net Income | |||||
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -7.144 | -32.087 | -10.125 | -5.252 | -2.21 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -7.144 | -32.087 | -10.125 | -5.252 | -2.21 |
Popravljen čisti dobiček | -7.144 | -32.087 | -10.125 | -5.252 | -2.21 |
Popravljene ponderirane povprečne delnice | 0.58736 | 0.56513 | 0.5666 | 0.56354 | 0.56167 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -12.163 | -56.7784 | -17.8697 | -9.31959 | -3.93473 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -12.163 | -56.7784 | -17.8697 | -9.31959 | -3.93473 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 16.343 | 45.692 | 32.594 | 13.8926 | 6.01088 |
Denarna sredstva in kratkoročne naložbe | 12.897 | 28.864 | 14.3679 | 9.30141 | 3.42337 |
Cash | 12.897 | 28.864 | 14.3679 | 9.30141 | 3.42337 |
Celotne terjatve, neto | 2.151 | 13.786 | 14.1449 | 3.52708 | 1.57433 |
Accounts Receivable - Trade, Net | 2.151 | 13.786 | 14.1449 | 3.52708 | 1.57433 |
Total Inventory | 0.757 | 2.651 | 1.92962 | 0.76799 | 0.58722 |
Prepaid Expenses | 0.538 | 0.391 | 2.15153 | 0.29613 | 0.42596 |
Total Assets | 30.873 | 60.417 | 47.4516 | 17.7326 | 8.7503 |
Property/Plant/Equipment, Total - Net | 14.144 | 14.269 | 14.4317 | 3.84005 | 2.73942 |
Total Current Liabilities | 5.506 | 11.773 | 12.4943 | 5.55881 | 4.60965 |
Accounts Payable | 1.523 | 7.246 | 8.36486 | 2.01183 | 2.03972 |
Accrued Expenses | 2.767 | 3.444 | 3.16567 | 2.82266 | 1.92839 |
Notes Payable/Short Term Debt | 0.117 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.099 | 1.083 | 0.96373 | 0.72433 | 0.64154 |
Total Liabilities | 22.013 | 22.937 | 23.7592 | 6.532 | 5.70778 |
Total Long Term Debt | 1.2 | 1.428 | 1.45955 | 0.97319 | 0.98502 |
Long Term Debt | |||||
Capital Lease Obligations | 1.2 | 1.428 | 1.45955 | 0.97319 | 0.98502 |
Other Liabilities, Total | 15.307 | 9.736 | 9.80536 | 0 | 0.11312 |
Total Equity | 8.86 | 37.48 | 23.6924 | 11.2006 | 3.04252 |
Common Stock | 0.002 | 0.002 | 0.00134 | 0.00547 | 0.00046 |
Additional Paid-In Capital | 307.296 | 303.829 | 287.218 | 256.912 | 223.5 |
Retained Earnings (Accumulated Deficit) | -298.438 | -266.351 | -263.527 | -245.717 | -220.458 |
Total Liabilities & Shareholders’ Equity | 30.873 | 60.417 | 47.4516 | 17.7326 | 8.7503 |
Total Common Shares Outstanding | 0.56895 | 0.5616 | 0.44652 | 0.18244 | 0.01543 |
Property/Plant/Equipment, Total - Gross | 19.467 | 18.902 | 19.005 | 8.09834 | |
Accumulated Depreciation, Total | -5.323 | -4.633 | -4.5733 | -4.2583 | |
Other Current Liabilities, Total | 0 | ||||
Other Long Term Assets, Total | 0.386 | 0.456 | 0.42591 | ||
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Total Preferred Shares Outstanding | 0.00209 | 0.00211 | 0.00211 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 9.09 | 16.343 | 27.263 | 43.778 | 47.584 |
Denarna sredstva in kratkoročne naložbe | 6.774 | 12.897 | 18.021 | 22.928 | 27.566 |
Cash | 6.774 | 12.897 | 18.021 | 22.928 | 27.566 |
Celotne terjatve, neto | 1.112 | 2.151 | 6.396 | 17.376 | 16.351 |
Accounts Receivable - Trade, Net | 1.112 | 2.151 | 6.396 | 17.376 | 16.351 |
Total Inventory | 0.704 | 0.757 | 1.897 | 2.249 | 3.221 |
Prepaid Expenses | 0.5 | 0.538 | 0.949 | 1.225 | 0.446 |
Total Assets | 22.993 | 30.873 | 41.73 | 58.142 | 61.944 |
Property/Plant/Equipment, Total - Net | 13.517 | 14.144 | 14.075 | 13.868 | 13.889 |
Property/Plant/Equipment, Total - Gross | 19.026 | 19.467 | 19.214 | 18.828 | 18.701 |
Accumulated Depreciation, Total | -5.509 | -5.323 | -5.139 | -4.96 | -4.812 |
Other Long Term Assets, Total | 0.386 | 0.386 | 0.392 | 0.496 | 0.471 |
Total Current Liabilities | 4.392 | 5.506 | 7.148 | 9.613 | 14.096 |
Accounts Payable | 1.533 | 1.523 | 3.04 | 4.83 | 8.076 |
Accrued Expenses | 1.841 | 2.767 | 2.671 | 3.206 | 4.999 |
Notes Payable/Short Term Debt | 0 | 0.117 | 0.384 | 0.524 | 0 |
Current Port. of LT Debt/Capital Leases | 1.018 | 1.099 | 1.053 | 1.053 | 1.021 |
Total Liabilities | 20.565 | 22.013 | 23.584 | 25.686 | 24.915 |
Total Long Term Debt | 1.011 | 1.2 | 1.009 | 0.957 | 1.221 |
Capital Lease Obligations | 1.011 | 1.2 | 1.009 | 0.957 | 1.221 |
Other Liabilities, Total | 15.162 | 15.307 | 15.427 | 15.116 | 9.598 |
Total Equity | 2.428 | 8.86 | 18.146 | 32.456 | 37.029 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
Additional Paid-In Capital | 308.008 | 307.296 | 306.874 | 306.825 | 306.146 |
Retained Earnings (Accumulated Deficit) | -305.582 | -298.438 | -288.73 | -274.371 | -269.119 |
Total Liabilities & Shareholders’ Equity | 22.993 | 30.873 | 41.73 | 58.142 | 61.944 |
Total Common Shares Outstanding | 0.59291 | 0.56895 | 0.5616 | 0.56404 | 0.56162 |
Total Preferred Shares Outstanding | 0.00209 | 0.00209 | 0.00211 | 0.00211 | 0.00209 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -32.087 | -2.824 | -17.8069 | -25.138 | -24.5716 |
Denarna sredstva iz poslovanja | -13.289 | 3.69 | -19.7871 | -23.0493 | -22.3552 |
Denarna sredstva iz poslovanja | 1.655 | 1.53 | 1.08523 | 0.93166 | 0.80091 |
Nedenarne postavke | 3.858 | 5.536 | 3.20213 | 2.55652 | 0.61434 |
Cash Taxes Paid | 0 | 0 | 0 | 0.00452 | |
Denarna sredstva Plačane obresti | 0.316 | 0.29 | 0.23654 | 0.24998 | 0.60549 |
Spremembe v obratnem kapitalu | 13.285 | -0.552 | -6.26756 | -1.3994 | 0.80114 |
Denarna sredstva pri naložbenju | -0.807 | -1.572 | -0.86681 | -0.7353 | -0.14525 |
Kapitalski izdatki | -0.807 | -1.572 | -0.86681 | -0.7353 | -0.14525 |
Celotne druge postavke denarnih tokov pri naložbenju | |||||
Denarna sredstva pri financiranju | -1.871 | 12.378 | 25.7204 | 29.6626 | 23.7772 |
Izdaja (odplačilo) delnic, neto | 0.24 | 14.15 | 27.2556 | 30.5955 | 25.6947 |
Izdaja (odplačilo) dolga, neto | -2.111 | -1.772 | -1.53514 | -0.93287 | -1.91744 |
Neto sprememba denarnih sredstev | -15.967 | 14.496 | 5.06654 | 5.87803 | 1.27676 |
Postavke denarnega toka pri financiranju | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -7.144 | -32.087 | -13.565 | -8.021 | -2.768 |
Cash From Operating Activities | -6.194 | -13.289 | -9.047 | -4.972 | -0.932 |
Cash From Operating Activities | 0.467 | 1.655 | 1.217 | 0.81 | 0.405 |
Non-Cash Items | 0.463 | 3.858 | 3.854 | 3.17 | 2.809 |
Cash Interest Paid | 0.046 | 0.316 | 0.269 | 0.217 | 0.061 |
Changes in Working Capital | 0.02 | 13.285 | -0.553 | -0.931 | -1.378 |
Cash From Investing Activities | -0.091 | -0.807 | -0.671 | -0.315 | -0.098 |
Capital Expenditures | -0.091 | -0.807 | -0.671 | -0.315 | -0.098 |
Cash From Financing Activities | 0.162 | -1.871 | -1.125 | -0.649 | -0.268 |
Issuance (Retirement) of Stock, Net | 0.396 | 0.24 | 0.239 | 0.094 | 0 |
Issuance (Retirement) of Debt, Net | -0.234 | -2.111 | -1.364 | -0.743 | -0.268 |
Net Change in Cash | -6.123 | -15.967 | -10.843 | -5.936 | -1.298 |
Cash Taxes Paid |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Renaissance Technologies LLC | Hedge Fund | 0.4395 | 6458 | 1048 | 2023-03-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.3583 | 5264 | 0 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3042 | 4470 | -113 | 2023-03-31 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.2137 | 3140 | -508 | 2023-03-31 | LOW |
HRT Financial LP | Investment Advisor | 0.1255 | 1844 | 1844 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.0921 | 1353 | 0 | 2023-03-31 | LOW |
Sabby Management, LLC | Investment Advisor/Hedge Fund | 0.0672 | 987 | -30 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.0608 | 894 | 0 | 2023-03-31 | LOW |
Taylor & Morgan Asset Management, LLC | Investment Advisor | 0.059 | 867 | 0 | 2023-03-31 | LOW |
Jane Street Capital, L.L.C. | Research Firm | 0.0576 | 847 | 847 | 2023-03-31 | HIGH |
Susquehanna International Group, LLP | Investment Advisor | 0.051 | 749 | 344 | 2023-03-31 | MED |
Ergoteles Capital | Hedge Fund | 0.05 | 734 | 734 | 2023-03-31 | HIGH |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 0.0314 | 462 | 0 | 2023-03-31 | MED |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.0263 | 387 | -22 | 2023-03-31 | LOW |
Goldman Sachs & Company, Inc. | Research Firm | 0.0247 | 363 | 363 | 2023-03-31 | MED |
Tower Research Capital LLC | Hedge Fund | 0.019 | 279 | -1 | 2023-03-31 | HIGH |
Citadel Advisors LLC | Hedge Fund | 0.0186 | 274 | -73 | 2023-03-31 | HIGH |
Group One Trading, L.P. | Research Firm | 0.0182 | 267 | 240 | 2023-03-31 | HIGH |
UBS Financial Services, Inc. | Investment Advisor | 0.01 | 147 | -127 | 2023-03-31 | LOW |
City National Rochdale, LLC | Investment Advisor/Hedge Fund | 0.0079 | 116 | 0 | 2023-03-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Biocept, Inc. Company profile
O družbi Biocept, Inc.
Biocept, Inc. je podjetje za molekularno onkološko diagnostiko. Družba se osredotoča na razvoj in trženje kliničnih diagnostičnih laboratorijskih testov za identifikacijo tumorskih celic in tumorske deoksiribonukleinske kisline (DNK) iz krvi in cerebrospinalne tekočine (CSF). Njegov izdelek je zaščiten z blagovno znamko CNSide. Poleg zdravila CNSide njegovo trenutno testiranje na osnovi krvi vključuje tehnologije Target Selector, ki omogočajo odkrivanje specifičnih genskih mutacij, kot so EGFR, KRAS ali BRAF, v brezcelični ctDNA iz vzorcev krvi ter specifičnih sprememb beljakovin in genov, kot je amplifikacija HER2, v krožečih tumorskih celicah (CTC), izoliranih iz krvi. Njegova multimodalna kombinacija metode zajemanja in analize celic, ki se uporablja s pristopom brezcelične tumorske DNK, zagotavlja visoko občutljivost in specifičnost ter se uporablja za vrsto diagnostičnih aplikacij pri bolnikih z metastatskim karcinomom. Zagotavlja tehnologijo tekoče biopsije na osnovi krvi.
Industry: | Laboratory Diagnostic & Testing Substances |
9955 Mesa Rim Road
SAN DIEGO
CALIFORNIA 92121
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com